Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Hypertension I: Introduction01:28

Hypertension I: Introduction

659
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
659
Hormonal Regulation01:33

Hormonal Regulation

35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

1.8K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Idiopathic anaphylaxis and histamine dysregulation: Revisiting pathophysiologic assumptions.

The Nurse practitioner·2026
Same journal

Improving anxiety screening for adults with hypertension: An integrative review.

The Nurse practitioner·2026
Same journal

Modality matters: Standard of care in telehealth.

The Nurse practitioner·2026
Same journal

Updates in care for patients with genitourinary syndrome of menopause.

The Nurse practitioner·2026
Same journal

Updates in care for patients with genitourinary syndrome of menopause.

The Nurse practitioner·2026
Same journal

UpToDate®.

The Nurse practitioner·2026

Related Experiment Video

Updated: Jan 8, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.1K

Recognizing and managing primary aldosteronism in hypertension.

Bernadette Sherman1

  • 1Bernadette Sherman is the Program Director and Assistant Professor, MSN FNP at Saint Francis University in Loretto, PA.

The Nurse Practitioner
|December 23, 2025
PubMed
Summary

Screening for hyperaldosteronism is crucial for all hypertension patients. Effective treatments include surgery and medication, but better education is needed for improved diagnosis and care.

Keywords:
hyperaldosteronismhypertensionprimary aldosteronismsecondary aldosteronism

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

627

Related Experiment Videos

Last Updated: Jan 8, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.1K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

627

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Hypertension is a prevalent condition with significant cardiovascular risks.
  • Hyperaldosteronism is an underdiagnosed cause of secondary hypertension.
  • Early detection and management of hyperaldosteronism can mitigate associated complications.

Purpose of the Study:

  • To emphasize the necessity of screening hypertensive individuals for hyperaldosteronism.
  • To outline current therapeutic strategies for primary aldosteronism.
  • To highlight the need for enhanced medical education on this topic.

Main Methods:

  • This study is a review and synthesis of current clinical guidelines and research.
  • It focuses on diagnostic criteria and treatment options for hyperaldosteronism.
  • The importance of patient education and physician awareness is discussed.

Main Results:

  • Screening for hyperaldosteronism should be a routine part of hypertension management.
  • Treatment options include surgical intervention (adrenalectomy) and pharmacological approaches (mineralocorticoid receptor antagonists).
  • There is a notable gap in current medical education regarding hyperaldosteronism.

Conclusions:

  • Implementing universal screening for hyperaldosteronism in hypertensive patients is recommended.
  • Tailored treatment, including surgery or medication, can effectively manage primary aldosteronism.
  • Improved educational initiatives are essential to enhance the diagnosis and treatment of hyperaldosteronism.